We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Simple Blood Test Can Detect Injury and Mild Concussion

By LabMedica International staff writers
Posted on 25 Apr 2016
Print article
A simple blood has detected evidence of concussions in patients up to seven days after their injury, which could greatly expand the window for diagnosing concussions, especially in patients who experience a delayed onset of symptoms.

Almost all concussions in children are diagnosed only by symptoms, which are either observed, like vomiting or loss of balance, or symptoms reported by the child, like blurred vision or headache and neither scenario gives doctors and objective way to determine the severity of the injury.

Investigators at the Orlando Regional Medical Center (Orlando, FL, USA) enrolled adult trauma patients seen at a level I trauma center from March 1, 2010, to March 5, 2014 in a prospective cohort study. A total of 1,831 blood samples were drawn over seven days from 584 patients, mean age, 40 ±16 years; and 62.0% were male. Repeated blood sampling was conducted at 4, 8, 12, 16, 20, 24, 36, 48, 60, 72, 84, 96, 108, 120, 132, 144, 156, 168, and 180 hours after injury.

The biomarkers glial fibrillary acidic protein (GFAP) and ubiquitin C- terminal hydrolase L1 (UCH-L1) were measured. These proteins are found in glial cells, which surround neurons in the brain, and when an injury occurs, the GFAP are released. What makes them unique is that they pass the blood-brain barrier and enter the bloodstream, making them easy to detect with this particular test. Both GFAP and UCH-L1 were detectible within one hour of injury. GFAP peaked at 20 hours after injury and slowly declined over 72 hours. UCH-L1 rose rapidly and peaked at eight hours after injury and declined rapidly over 48 hours. Over the course of one week, GFAP demonstrated a diagnostic range of areas under the curve for detecting mild to moderate traumatic brain injury (MMTBI) of 0.73 to 0.94, and UCH-L1 demonstrated a diagnostic range of 0.30. For distinguishing patients with and without a neurosurgical intervention, the range for GFAP was 0.91 to 1.00 and the range for UCH-L1 was 0.50 to 0.92.

Linda Papa, MD, MSC, an emergency medicine physician, and lead author of the study, said, “This blood test could ultimately change the way we diagnose concussions, not only in children, but in anyone who sustains a head injury. We have so many diagnostic blood tests for different parts of the body, like the heart, liver and kidneys, but there has never been a reliable blood test to identify trauma in the brain. We think this test could change that.” The study was published on March 28, 2016, in the journal JAMA Neurology.

Related Links:
Orlando Regional Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.